|
시장보고서
상품코드
2117923
모낭염 치료 시장 규모, 점유율 및 성장 분석 : 치료법별, 제형별, 유통 채널별, 최종사용자별, 적응증별, 지역별 - 업계 예측(2026-2033년)Folliculitis Treatment Market Size, Share, and Growth Analysis, By Treatment Type (Antibiotics, Antifungal Drugs), By Dosage Form (Topical, Oral), By Distribution Channel, By End User, By Indication, By Region - Industry Forecast 2026-2033 |
||||||
세계의 모낭염 치료 시장 규모는 2024년에 32억 6,000만 달러로 평가되며, 2025년 35억 1,000만 달러에서 2033년까지 63억 1,000만 달러로 확대하며, 예측 기간(2026-2033년)에 CAGR 7.6%로 성장할 것으로 전망되고 있습니다.
전 세계 모낭염 치료 시장은 전 세계 수많은 환자에게 영향을 미치는 모낭의 염증성 감염을 치료하기 위한 의약품, 외용 소독제 및 혁신적인 생물제제로 구성되어 있습니다. 이 시장의 중요성은 이 질환이 환자의 삶의 질에 미치는 영향과 미용 치료에 대한 수요 증가에 기인하며, 이로 인해 의료 서비스 제공자와 보험사는 효과적인 해결책에 주력하고 있습니다. 기존에는 제네릭 항생제가 주류를 이루었으나, 내성 및 부작용에 대한 우려로 인해 레타파무린이나 광선요법 등의 대체요법으로의 전환이 진행되고 있습니다. 현재 비항생제 치료법에 대한 관심이 높아지면서, 광역학 요법이나 피부 미생물군집의 건강을 지원하는 실리콘계 배리어 크림과 같은 솔루션에 대한 투자가 촉진되고 있습니다. 이러한 변화는 제약사와 의료기기 제조업체 간의 제휴를 촉진하여 새로운 수입원으로의 길을 열어주고 있습니다.
전 세계 모낭염 치료 시장의 성장 요인
예방적 피부 관리에 대한 대중의 관심이 높아지면서, 의료 전문가들이 조기 개입을 권장하고 있는 점도 맞물려 효과적인 모낭염 치료법에 대한 수요가 크게 증가하고 있습니다. 이러한 인식의 확산으로 환자들은 처방약과 일반의약품 모두를 치료 옵션으로 고려하게 되었으며, 이에 따라 소비자 시장이 확대되고 있습니다. 얼굴과 두피 위생 관리에 대한 관심이 높아짐에 따라 사람들은 염증을 완화하고 증상 재발을 방지하기 위한 표적 치료법을 채택하는 경향이 강해지고 있으며, 이는 다양한 계층에서 시장의 지속적인 성장을 촉진하고 있습니다. 또한 디지털 헬스 플랫폼의 보급으로 교육 자료 및 전문적인 치료 프로토콜에 대한 접근성이 향상되면서, 소비자의 신뢰가 더욱 높아지고 이 분야의 재구매가 촉진되고 있습니다.
전 세계 모낭염 치료 시장의 제약 요인
전 세계 모낭염 치료 시장은 다양한 지역에서 인증된 피부과 전문의의 부족으로 인해 큰 제약을 받고 있습니다. 이러한 부족으로 인해 환자들이 모낭염에 대한 정확한 진단이나 효과적인 치료를 받는 데 어려움이 있습니다. 그 결과, 많은 환자들은 피부과 이 전문 분야에 필요한 전문 지식을 갖추지 못했을 가능성이 있는 일반의에게 의존할 수밖에 없습니다. 이러한 의존은 치료 시작의 지연이나 증상 관리에 있으며, 최적의 선택이 아닌 결과를 초래하는 경우가 많습니다. 그 결과, 많은 잠재적 환자들이 치료를 받지 못한 채 방치되거나 자가 치료에 의존하게 되어, 궁극적으로 시장의 성장과 효과성을 저해하게 됩니다.
전 세계 모낭염 치료 시장의 동향
전 세계 모낭염 치료 시장에서는 접근성이 높은 의료 솔루션에 대한 수요가 증가함에 따라 원격 피부과 서비스로의 뚜렷한 전환이 나타나고 있습니다. 이러한 동향으로 인해 환자들은 온라인 진료를 통해 모낭염에 대한 신속한 평가와 치료 지도를 받을 수 있게 되어 편의성이 향상될 뿐만 아니라, 의료 서비스가 미치지 않는 지역으로의 시장 확대가 촉진되고 있습니다. 피부과 의사들은 진단 정확도 향상과 치료법의 개인화를 도모하기 위해 고해상도 영상 진단 및 인공지능(AI) 등의 첨단 기술을 점점 더 많이 활용하고 있습니다. 또한 디지털 처방 솔루션의 부상으로 제약사들은 원격 모니터링에 대응하는 제제 개발에 주력하고 있으며, 이를 통해 맞춤형 치료가 실현되고 환자의 치료 계획 준수율도 향상되고 있습니다.
자주 묻는 질문
목차
서론
조사 방법
개요
시장 역학과 전망
주요 시장 인사이트
세계의 모낭염 치료 시장 규모 : 치료 유형별
세계의 모낭염 치료 시장 규모 : 제형별
세계의 모낭염 치료 시장 규모 : 유통 채널별
세계의 모낭염 치료 시장 규모 : 최종사용자별
세계의 모낭염 치료 시장 규모 : 적응증별
세계의 모낭염 치료 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSA 26.08.27Global Folliculitis Treatment Market size was valued at USD 3.26 Billion in 2024 and is poised to grow from USD 3.51 Billion in 2025 to USD 6.31 Billion by 2033, growing at a CAGR of 7.6% during the forecast period (2026-2033).
The global folliculitis treatment market consists of pharmaceuticals, topical antiseptics, and innovative biologics aimed at addressing inflammatory hair follicle infections that affect a significant number of individuals worldwide. The market's importance arises from the condition's impact on patient well-being and the increasing demand for aesthetic treatments, prompting healthcare providers and insurers to focus on effective solutions. Traditionally dominated by generic antibiotics, the market is experiencing a transition towards alternatives like retapamulin and light-based therapies due to concerns over resistance and side effects. There is now a growing emphasis on non-antibiotic therapies, driving investment in solutions like photodynamic therapy and silicone-based barrier creams that support skin microbiome health. This shift is fostering collaborations between manufacturers and device companies, paving the way for new revenue streams.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Folliculitis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Folliculitis Treatment Market Segments Analysis
Global folliculitis treatment market is segmented by treatment type, dosage form, distribution channel, end user, indication and region. Based on treatment type, the market is segmented into Antibiotics, Antifungal Drugs, Corticosteroids and Antiseptics. Based on dosage form, the market is segmented into Topical, Oral and Injectable. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on end user, the market is segmented into Hospitals, Dermatology Clinics and Homecare. Based on indication, the market is segmented into Bacterial Folliculitis, Fungal Folliculitis and Viral Folliculitis. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Folliculitis Treatment Market
The rising public interest in preventive skin care significantly boosts the demand for effective folliculitis treatments, as healthcare professionals advocate for early intervention. This growing awareness encourages patients to explore both prescription and over-the-counter solutions, broadening the consumer market. With an increased focus on maintaining facial and scalp hygiene, individuals are more inclined to adopt targeted therapies that reduce inflammation and prevent flare-ups, promoting ongoing market growth across various demographic groups. Additionally, the proliferation of digital health platforms enhances access to educational resources and specialized treatment protocols, which further strengthens consumer confidence and fosters repeat purchases in this sector.
Restraints in the Global Folliculitis Treatment Market
The Global Folliculitis Treatment market faces significant constraints due to a shortage of board-certified dermatologists in various regions. This scarcity impedes patients' access to accurate diagnoses and effective treatments for folliculitis. As a result, many individuals must rely on general practitioners who may not possess the necessary expertise in this specialized area of dermatology. This reliance often leads to delays in initiating treatment and choices that may not be optimal for managing their condition. Consequently, numerous potential patients either remain untreated or resort to self-treatment, ultimately hindering the growth and effectiveness of the market.
Market Trends of the Global Folliculitis Treatment Market
The Global Folliculitis Treatment market is witnessing a notable shift towards tele-dermatology services, driven by the growing demand for accessible healthcare solutions. This trend allows patients to receive prompt assessments and treatment guidance for folliculitis through virtual consultations, enhancing convenience and expanding market reach to underserved areas. Dermatologists are increasingly utilizing advanced technologies, such as high-resolution imaging and artificial intelligence, to improve diagnostic accuracy and tailor treatment approaches. Additionally, the rise of digital prescription solutions is prompting pharmaceutical companies to innovate formulations that are compatible with remote monitoring, leading to personalized care and improved patient adherence to treatment regimens.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Folliculitis Treatment Market Size by Treatment Type & CAGR (2026-2033)
- Market Overview
- Antibiotics
- Antifungal Drugs
- Corticosteroids
- Antiseptics
Global Folliculitis Treatment Market Size by Dosage Form & CAGR (2026-2033)
- Market Overview
- Topical
- Oral
- Injectable
Global Folliculitis Treatment Market Size by Distribution Channel & CAGR (2026-2033)
- Market Overview
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Folliculitis Treatment Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Dermatology Clinics
- Homecare
Global Folliculitis Treatment Market Size by Indication & CAGR (2026-2033)
- Market Overview
- Bacterial Folliculitis
- Fungal Folliculitis
- Viral Folliculitis
Global Folliculitis Treatment Market Size & CAGR (2026-2033)
- North America (Treatment Type, Dosage Form, Distribution Channel, End User, Indication)
- US
- Canada
- Europe (Treatment Type, Dosage Form, Distribution Channel, End User, Indication)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Treatment Type, Dosage Form, Distribution Channel, End User, Indication)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Treatment Type, Dosage Form, Distribution Channel, End User, Indication)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Treatment Type, Dosage Form, Distribution Channel, End User, Indication)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Pfizer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sanofi S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AbbVie Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bausch Health Companies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Galderma S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Viatris Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sun Pharmaceutical Industries Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Dr. Reddy's Laboratories Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Aurobindo Pharma Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Almirall S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LEO Pharma A/S
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GlaxoSmithKline plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mayne Pharma Group Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Taro Pharmaceutical Industries Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cipla Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Perrigo Company plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bausch + Lomb Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
(주말 및 공휴일 제외)
